CIK 0001665988 · Accelerated filer<br>Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 810980861
- Phone
- (919) 474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4/A Other disposition Director disposed of 2,604,264 shares (other)
- 3/A Insider 3/A
- 4 Open-market buy Interim CEO bought 39,885 shares at $4.14 ($165,076)
- 4 Other acquisition Director acquired 41,369 shares (other)
- 4 Open-market buy Director bought 65,022 shares at an average $4.64 ($301,688)
- 4 Open-market buy 10% owner bought 176,870 shares at an average $4.52 ($799,907)
- 4 Open-market buy Director bought 111,848 shares at $4.47 ($500,419)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale SVP & Chief Compliance Officer sold 394 shares at $2.83 ($1,115)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 1,813 shares (option exercise)
- 4 Option exercise Director acquired 386 shares (option exercise)
- 4 Option exercise Director acquired 965 shares (option exercise)
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 11 of 24 · 463 filings